[BDRX] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
30-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -137.62%
YoY- 26.44%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 84 226 275 237 1,476 162 18 29.24%
PBT -8,930 -2,626 -3,255 -3,340 -4,785 -2,625 -1,587 33.33%
Tax 220 416 445 322 683 178 188 2.65%
NP -8,710 -2,210 -2,810 -3,018 -4,103 -2,447 -1,399 35.59%
Tax Rate - - - - - - - -
Total Cost 8,794 2,436 3,085 3,255 5,578 2,609 1,417 35.52%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -10,369.05 -977.65 -1,023.68 -1,276.11 -278.04 -1,510.49 -7,772.22 4.91%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
EPS Diluted 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.